Abstract
The self life of the freeze-dried formulation kits utilized for the preparation of the new bone imaging radiopharmaceutical99mTc-1,2-dihydroxy-1,2-bis/dihydroxyphosphinyl/ethane /99mTc-DHPE/ has been investigated as well as the toxicity of the DHPE. In a biodistribution investigation of99mTc-DHPE in rats, in comparison to99mTc-methylenediphosphanate /99mTc-MDP/,99mTc-DHPE exhibited a certain extent higher skeleton uptake, a higher blood clearance rate, a very low concentration in other organs, a satisfactory biological stability and excretion primarily through the kidneys. These properties demonstrate that99mTc-DHPE is a new promising skeleton imaging radio-pharmaceutical.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Radioanalytical and Nuclear Chemistry Letters
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
